David M. Greer, MD

Chair, Neurology

David Greer
617.638.8456
75 East Newton Street

Biography

Dr. David Greer is Professor and Chair of the Department of Neurology at Boston University School of Medicine and the Richard B. Slifka Chief of Neurology at Boston Medical Center. He has been a neurointensivist since 2001, having trained at Massachusetts General Hospital, where he began his career. He was then Vice Chair at Yale from 2010-17, before joining Boston University and Boston Medical Center in 2017.

Dr. Greer has been editor-in-chief of Seminars in Neurology since 2013, and was the inaugural editor-in-chief for Neurocritical Care on Call. He has authored more than 350 peer-reviewed manuscripts, reviews, chapters, guidelines and books. He helped create the NCS Brain Death Toolkit, and has previously served the Neurocritical Care Society on both the Board of Directors and the Executive Committee, and is the current Treasurer for NCS.

His research interests include predicting recovery from coma after cardiac arrest, brain death, and multiple stroke-related topics, including acute stroke treatment, temperature modulation and stroke prevention. He is the co-PI for the INTREPID study, evaluating fever prevention for acute vascular brain injury, and is an R01-funded investigator evaluating multi-modality imaging and EEG for assessing neuroprognosis after cardiac arrest. He was the lead author for the World Brain Death Project, and the lead author for the 2023 AAN Practice Parameters in Brain Death.

Dr. Greer’s greatest passion is in education in mentorship. In 2022, he received the prestigious A.B. Baker Lifetime Achievement Award for Neurological Education from the American Academy of Neurology. He has mentored innumerable students, residents, fellows and faculty, and considers himself a “lifelong mentor” for anyone and everyone he takes under his wing.

Dr. Greer is the editor-in-chief of both Neurocritical Care Live and Seminars in Neurology. He serves as a reviewer for several journals, including the New England Journal of Medicine, Annals of Internal Medicine, Brain, Neurology, and Stroke. He is a fellow of the Society of Critical Care Medicine, American Academy of Neurology, American Heart Association, American Neurological Association and Neurocritical Care Society. He has authored more than 150 peer-reviewed manuscripts, reviews, chapters, guidelines and books.

Other Positions

  • Chief, Neurology, Boston Medical Center
  • Professor, Neurology, Boston University Chobanian & Avedisian School of Medicine

Education

  • University of Florida College of Medicine, MD
  • University of Florida, MA
  • Williams College, BA

Publications

  • Published on 2/19/2025

    Cobler-Lichter MJ, Suchdev K, Tatro H, Cascone A, Yang J, Weinberg J, Abdalkader MK, Dasenbrock HH, Ong CJ, Cervantes-Arslanian A, Greer D, Nguyen TN, Daneshmand A, Chung DY. Safety and Outcomes of Valproic Acid in Subarachnoid Hemorrhage Patients: A Retrospective Study. Clin Neuropharmacol. 2025 Mar-Apr 01; 48(2):43-50. PMID: 40035592.

    Read at: PubMed
  • Published on 2/18/2025

    Greer DM, Sheth KN. Fever Prevention in Acute Vascular Brain Injury-Reply. JAMA. 2025 Feb 18; 333(7):636. PMID: 39841455.

    Read at: PubMed
  • Published on 1/28/2025

    Banna S, Schenck C, Kim N, Ali T, Gilmore EJ, Greer DM, Beekman R, Miller PE. Prevalence and Prognostic Impact of ST Segment Elevation in Lead aVR Among Patients with Cardiac Arrest. Eur Heart J Acute Cardiovasc Care. 2025 Jan 28. PMID: 39873390.

    Read at: PubMed
  • Published on 1/23/2025

    Landau D, Kirschen MP, Greer D, Lewis A. States Do Not Delineate the "Accepted Medical Standards" for Brain Death/Death by Neurologic Criteria Determination. Neurocrit Care. 2025 Jan 23. PMID: 39849222.

    Read at: PubMed
  • Published on 1/18/2025

    Du Y, Pohlmann JE, Chatzidakis S, Brush B, Malinger LA, Stafford RA, Cervantes-Arslanian AM, Benjamin EJ, Gilmore EJ, Dupuis J, Greer DM, Smirnakis SM, Mohammed S, Ong CJ. Quantitative Pupillometry Predicts Neurologic Deterioration in Patients with Large Middle Cerebral Artery Stroke. Ann Neurol. 2025 May; 97(5):930-941. PMID: 39825740.

    Read at: PubMed
  • Published on 1/17/2025

    Greer DM. Nuri S. Jacoby, MD, and Yaacov Anziska, MD. Semin Neurol. 2025 Feb; 45(1):1. PMID: 39824173.

    Read at: PubMed
  • Published on 1/1/2025

    Reynolds AS, Suh J, Hasan A, Upadhyaya P, Rajajee V, Hirzallah MI, Greer DM, Sarwal A. Technical Considerations in the TCD Evaluation of Cerebral Circulatory Arrest in Death by Neurological Criteria. J Neuroimaging. 2025; 35(1):e70021. PMID: 39920886.

    Read at: PubMed
  • Published on 12/26/2024

    Stafford R, Chatzidakis S, Kim ISY, Zhang Y, Rina A, Brush B, Mian A, Abdalkader M, Greer DM, Smirnakis SM, Feske SK, Dupuis J, Ong CJ. Follow-up ASPECTS improves prediction of potentially lethal malignant edema in patients with large middle cerebral artery stroke. J Neurointerv Surg. 2024 Dec 26; 17(e1):e83-e86. PMID: 38160055.

    Read at: PubMed
  • Published on 12/2/2024

    Sharma M, Wahlster S, Town JA, Patel PV, Jannotta GE, Amorim E, Lewis A, Greer DM, Maia IS, Kross EK, Creutzfeldt CJ, Lobo SM. Perceptions and preferences about family visitation restrictions and psychological distress among critical care clinicians in Brazil: results from a national survey. Crit Care Sci. 2024; 36:e20240112en. PMID: 39630829.

    Read at: PubMed
  • Published on 11/26/2024

    Veerapaneni D, Sakthiyendran NA, Kim SY, Nguyen C, Daneshmand A, Abdalkader M, Mohammed S, Dupuis J, Sheth KN, Gilmore EJ, Greer D, Ong CJ. Pupil Abnormality Frequency in the First 72 Hours Improves IMPACT score in Traumatic Brain Injury. medRxiv. 2024 Nov 26. PMID: 39649617.

    Read at: PubMed

View 308 more publications: View full profile at BUMC

View all profiles